PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2026Microscopy Research and Technique0 citations

Detection of Lung and Colon Cancer Using XRx ‐Net With Histopathological Images

View Full Paper
ZSZulaikha Beevi SulaimanSBSarojini BalakrishnanRGRama Gaikwad

Key Points

  • The research investigates an efficient method for detecting lung and colon cancer using advanced imaging techniques.
  • Developed the XRx-Net framework combining Xception and ResNeXt models for classification.
  • Utilized histopathological images processed through an Adaptive Bilateral Filter.
  • Segmented cancerous cells using hookNet and extracted features with Wavelet texture analysis and CNNs.
  • Achieved a testing accuracy of up to 91.34%.
  • Reported a True Positive Rate of 92.36%.
  • Achieved a True Negative Rate of 90.14%.
  • Identified various outputs including lung and colon cancer types.

Abstract

ABSTRACT Lung and Colon Cancer (LCC) is a prevalent type of cancer influenced by factors such as genetics, smoking, second‐hand smoke exposure, and alcohol consumption. Traditionally, cancer diagnosis, including grading and staging, relies on histopathology, where pathologists examine samples under a microscope. This process is time‐consuming and complex. To address these challenges, the Xception ResNeXT Network (XRx‐Net) framework is introduced for more efficient LCC detection. In this approach, histopathological images of LCC are processed through an Adaptive Bilateral Filter (ABF) for initial filtering. Next, hookNet is used to segment the cancerous cells. Features are then extracted using Wavelet texture analysis and Convolutional Neural Networks (CNNs). Later, these features are input into the LCC detection phase, where the XRx‐Net framework is a combination of the Xception model and ResNeXt Networks employed for classification. The framework successfully identifies various outputs, including lung benign tissue, lung adenocarcinoma, lung squamous cell carcinoma, colon benign tissue, and colon adenocarcinoma. The XRx‐Net framework achieves a testing accuracy of up to 91.34%, with a True Positive Rate (TPR) of 92.36% and a True Negative Rate (TNR) of 90.14%.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sulaiman et al. (2026) studied this question.

synapsesocial.com/papers/69b4b9eb18185d8a39802380https://doi.org/10.1002/jemt.70122
Ask AI
Helpful
Bookmark
Share
View Full Paper